Purchase Order HHSN272201701340P
- Not listed
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $50,203.50 firm fixed-price purchase order is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Nanostring Technologies, Inc., a public company that provides advanced genomic analysis platforms and life science tools. The $19,920.00 firm fixed price contract is for the purchase of Nanostring's nCounter Analysis Systems and related consumable products to support biomedical research and healthcare programs across various government...
- This contract award to Nanostring Technologies, Inc. is for the delivery of the company's specialized nCounter RNA analysis systems, reagents, and related consumables to support biomedical research and healthcare programs for the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The $6,100 firm fixed-price purchase order includes the supply of nCounter Analysis Systems, which enable multiplexed digital detection and...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $8,813 firm fixed-price purchase order is for the delivery of AMBIS# 1552919NCOUNTER GX CODESET-48 RXNS GXA-P1CS-048, No. 100021. This order is not associated with a set-aside program. Nanostring has...
- This $90,793 purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Nanostring Technologies, Inc., a provider of advanced genomic analysis platforms. The contract is for the procurement of consumable fluids for the GeoMx Digital Spatial Profiler, a novel technology that enables spatially-resolved, digital quantification of proteins and RNA in tissue samples. The award is not designated as a set-aside contract....
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nanostring Technologies, Inc. for $65,992.00. The contract is for the delivery of reagents and consumables for Nanostring's existing CosMx Spatial Molecular Imager, a genomic analysis platform used to support biomedical research and healthcare programs across various government agencies. Nanostring Technologies is a publicly held provider of life science...
- This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $6,895.00 firm fixed price purchase order was awarded on May 11, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for AMBIS# 1554864NCOUNTER GX CODESET--48 RXNS GXA-P1CS-048 (136 GEN X 48 RXNS). This contract has no set-aside designation. Nanostring is the prime...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Nanostring Technologies, Inc. The $18,660 firm fixed-price purchase order is for the supply of the NANOSTRING MOUSE IMMUNOLOGY KIT, catalog number GXA-MIMI-48. This award was not set aside for any specific business type. Nanostring Technologies is a publicly traded company that specializes in advanced genomic analysis platforms and life...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Nanostring Technologies, Inc., a for-profit manufacturer of advanced genomic analysis platforms and life science tools. The $9,999 firm fixed price purchase order was awarded on September 20, 2017 without the use of a set-aside program. Nanostring Technologies provides specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs across various government agencies. Under this award, the company likely supplied the NIAID with nCounter Analysis Systems, GeoMx Digital Spatial Profilers, reagents, and related consumables to enable multiplexed, digital detection and counting of nucleic acids, proteins, and cells. In addition to this specific purchase order, Nanostring holds two larger federal contract vehicles - a $596,881.45 IDIQ contract with the USDA Agricultural Research Service and a $2.8 million BPA with the Defense Health Agency. These agreements allow the company to provide a broader suite of its proprietary technologies and services to support ongoing government research initiatives in areas such as infectious disease diagnostics, vaccines, and therapeutics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/20/17 |